NCT02681991View on ClinicalTrials.gov

Phase Ⅳ Clinical Trial to Evaluate of Renamezin in Patients With Chronic Renal Failure.

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Chronic Renal Failure
Interventions
DRUG

Renamezin capsule

Trial Locations (1)

06273

Gangnam Sevrance Hospital of Yonsei University, Seoul

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY